Testicular Function After Long-Term Methylphenidate Treatment in Boys with Attention-Deficit/Hyperactivity Disorder

被引:6
作者
Wang, Liang-Jen [1 ,2 ]
Lee, Sheng-Yu [3 ,4 ]
Chou, Wen-Jiun [1 ,2 ]
Lee, Min-Jing [1 ,2 ]
Tsai, Ching-Shu [1 ,2 ]
Lee, Tung-Liang [5 ]
Yang, Chun-Ju [6 ]
Yang, Kang-Chung [6 ]
Chen, Chih-Ken [6 ,7 ,8 ]
Shyu, Yu-Chiau [6 ,9 ,10 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan
[2] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan
[3] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Sch Med, Grad Inst Med, Dept Psychiat,Coll Med, Kaohsiung, Taiwan
[5] Soochow Univ, Dept Microbiol, Taipei, Taiwan
[6] Keelung Chang Gung Mem Hosp, Community Med Res Ctr, Keelung 204, Taiwan
[7] Chang Gung Mem Hosp, Dept Psychiat, Keelung, Taiwan
[8] Chang Gung Univ, Coll Med, Keelung, Taiwan
[9] Acad Sinica, Inst Mol Biol, Taipei, Taiwan
[10] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan
关键词
ADHD; comorbidity; testosterone; epidemiology; psychostimulant; ENDOCRINE DISRUPTORS; STIMULANT MEDICATION; TESTOSTERONE; EXPOSURE; PARAMETERS; CHILDREN; SYSTEM; BRAIN;
D O I
10.1089/cap.2018.0126
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: Treating attention-deficit/hyperactivity disorder (ADHD) with methylphenidate (MPH) has become increasingly common, while both animal studies and case reports have previously suggested that MPH may exert adverse effects on the reproductive system or gonadal hormones. This study aims to investigate whether long-term MPH treatment of boys with ADHD can induce testicular dysfunction (TD). Methods: A nationwide cohort that included 59,746 boys diagnosed with ADHD and 52,008 healthy subjects retrieved from the National Health Insurance database in Taiwan was also observed between 1999 and 2011. TD was defined by the International Classification of Diseases, 9th revision, Clinical Modifications codes (257.0, 257.1, 257.2, 257.8, or 257.9). Cumulative time of MPH use was categorized into nonuse, short-term use (1-365 days), and long-term use (>365 days). We compared the rate of TD diagnosis between ADHD patients and controls and analyzed the risk of developing a TD after MPH treatment. Results: Compared with the control group (0.06%), the ADHD group had a higher comorbidity rate of TD (0.14%) (adjusted odds ratio [aOR] = 1.95, 95% confidence interval [95% CI]: 1.26-3.04, p = 0.003). However, MPH did not significantly influence the risk of developing TD (adjusted hazard ratio = 1.40, 95% CI: 0.77-2.54, p = 0.272). Compared with ADHD boys without MPH treatment, patients who were prescribed short-term MPH (aOR = 0.96, 95% CI: 0.51-1.82, p = 0.900) and long-term MPH (aOR = 1.40, 95% CI: 0.69-2.83, p = 0.351) showed no significance associated with an increased risk of developing TD. Conclusions: Our nationwide cohort showed that long-term treatment with MPH has no harmful effect on the testosterone function of ADHD patients. However, due to the increased comorbidity rate of ADHD and TD, early recognition and detection of TD in ADHD children have the potential to change the trajectory of TD morbidity later in life.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 50 条
[31]   Types of adult attention-deficit hyperactivity disorder (ADHD): baseline characteristics, initial response, and long-term response to treatment with methylphenidate [J].
Reimherr, Fred W. ;
Marchant, Barrie K. ;
Gift, Thomas E. ;
Steans, Tammy A. ;
Wender, Paul H. .
ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS, 2015, 7 (02) :115-128
[32]   Neurofeedback Treatment for Attention-Deficit/Hyperactivity Disorder in Children: A Comparison with Methylphenidate [J].
Thomas Fuchs ;
Niels Birbaumer ;
Werner Lutzenberger ;
John H. Gruzelier ;
Jochen Kaiser .
Applied Psychophysiology and Biofeedback, 2003, 28 :1-12
[33]   Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: A comparison with methylphenidate [J].
Fuchs, T ;
Birbaumer, N ;
Lutzenberger, W ;
Gruzelier, JH ;
Kaiser, J .
APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK, 2003, 28 (01) :1-12
[34]   A re psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder? [J].
Chan, Mandy H. ;
Leung, Patrick W. L. ;
Ho, Ting-pong ;
Hung, Se-fong ;
Lee, Chi-chiu ;
Tang, Chun-pan ;
Cheung, Ka-chai ;
Ching, Fung-yee ;
Chan, Fefe H. K. ;
Chen, Lu-hua ;
Garcia-Barcelo, Merce ;
Sham, Pak-chung .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 :1071-1079
[35]   Appetite hormones, neuropsychological function and methylphenidate use in children with attention-deficit/hyperactivity disorder [J].
Lai, Kuan-Yu ;
Li, Chia-Jung ;
Tsai, Ching-Shu ;
Chou, Wen-Jiun ;
Huang, Wan-Ting ;
You, Huey-Ling ;
Lee, Sheng-Yu ;
Wang, Liang-Jen .
PSYCHONEUROENDOCRINOLOGY, 2024, 170
[36]   Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate [J].
Levy, Florence .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 (07) :616-617
[37]   Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine [J].
Joseph, Alain ;
Cloutier, Martin ;
Guerin, Annie ;
Nitulescu, Roy ;
Sikirica, Vanja .
PATIENT PREFERENCE AND ADHERENCE, 2016, 10 :391-405
[38]   Methylphenidate for Comorbid Epilepsy and Attention-Deficit/Hyperactivity Disorder [J].
Naguy, Ahmed ;
Alrashidi, Fouziya ;
Elsori, Dalal .
AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (06) :E718-E720
[39]   Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder [J].
Weisler, Richard ;
Young, Joel ;
Mattingly, Greg ;
Gao, Joseph ;
Squires, Liza ;
Adler, Lenard .
CNS SPECTRUMS, 2009, 14 (10) :573-585
[40]   Personality Disorder in Adult Attention-Deficit/Hyperactivity Disorder Attrition and Change During Long-term Treatment [J].
Gift, Thomas E. ;
Reimherr, Frederick W. ;
Marchant, Barrie K. ;
Steans, Tammy A. ;
Wender, Paul H. .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 2016, 204 (05) :355-363